Associations between antiretroviral use and subclinical coronary atherosclerosis.
about
Positive Expression of Human Cytomegalovirus Phosphoprotein 65 in Atherosclerosis.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials.
P2860
Associations between antiretroviral use and subclinical coronary atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@en
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@nl
type
label
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@en
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@nl
prefLabel
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@en
Associations between antiretroviral use and subclinical coronary atherosclerosis.
@nl
P2093
P2860
P1433
P1476
Associations between antiretroviral use and subclinical coronary atherosclerosis
@en
P2093
Frank J Palella
Guajira P Thomas
John P Phair
Lisa P Jacobson
Mallory D Witt
Todd T Brown
Wendy S Post
Xiuhong Li
P2860
P304
P356
10.1097/QAD.0000000000001220
P407
P577
2016-10-01T00:00:00Z